Table 1.
DRI criteria | Total liver VA reserve µmol/g | Model | References |
---|---|---|---|
(1) No clinical signsXerophthalmic sequelae | <0.02 | Predicted for children | Olson8* |
(2) Adequate plasma retinolDepressed serum retinolconcentrations | >0.005<0.02<0.01<0.1 | RatsPredicted for childrenGerbilsAdult humans | Lewis et al.,28 High et al.,29 Riabroy et al.30Olson8*Kaeppler et al.31Olsen, Suri et al.7 |
(3) Induced biliary excretionEnhanced biliary secretion or excretion | >0.1 | Rats | Hicks et al.4Varma and Beaton35 |
(4) Protection for 4 monthsmRNA upregulation of LRAT |
>0.1 |
Rats |
Zolfaghari and Ross21 |
Biomarkers of VA status |
|
|
|
Positive dose response tests | <0.10 | Piglets, calves, rats, humans | Sheftel and Tanumihardjo45* |
Elevated provitaminA carotenoids | >0.7 >1 | Gerbils (liver) Humans (serum) | Tanumihardjo19*Sowa et al.61Mondloch et al.62 |
Elevated serum retinyl esters | ∼3 | Humans | Olsen, Suri et al.7 |
Retinol isotope dilution | Continuum | RatsNon-human primatesHumans | Tanumihardjo68 Escaron et al.69Tanumihardjo et al.2*Tanumihardjo19* |
Hepatic biopsy | Continuum | Humans | Olsen, Suri et al.7 |
These references are either a chapter in a book or reviews of multiple studies.